MDxHealth SA (OTCMKTS:MXDHF – Get Free Report)’s share price was down 9.1% during mid-day trading on Monday . The company traded as low as $0.25 and last traded at $0.25. Approximately 300 shares changed hands during trading, a decline of 70% from the average daily volume of 1,000 shares. The stock had previously closed at $0.28.
MDxHealth Price Performance
The company has a current ratio of 1.25, a quick ratio of 1.19 and a debt-to-equity ratio of 1.45. The business’s 50-day moving average price is $0.25.
MDxHealth Company Profile
MDxHealth SA, a commercial-stage precision diagnostics company, provides urologic solutions in the United States, Europe, and internationally. Its novel prostate cancer genomic testing solutions are SelectMDx, a non-invasive urine test; and ConfirmMDx, an epigenetic test, which provide physicians with a clinical pathway to identify clinically prostate cancer while minimizing the use of invasive procedures that are prone to complications.
Featured Stories
- Five stocks we like better than MDxHealth
- Procter & Gamble (NYSE:PG) Pulls Back After Shaky Guidance
- Whirlpool’s High Dividend Yield Is Too Good to Pass Up
- How to Invest in Blue Chip Stocks
- Holiday Spending Boom Ahead: 3 BNPL Stocks Poised for Gains
- Investing In Preferred Stock vs. Common Stock
- Boeing: A Perfect Storm of Trouble Is a Loaded Buying Opportunity
Receive News & Ratings for MDxHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MDxHealth and related companies with MarketBeat.com's FREE daily email newsletter.
